A potential role of ACSM3 in MetS is further supported by associations of ACSM3 polymorphisms with obesity, hypertriglyceridemia, and hypertension in patient cohorts (Iwai et al, 2002; Telgmann et al, 2007). This evidence concerns the gene ACSM3 and obesity due to melanocortin 4 receptor deficiency.